高级检索
    刘晓晴, 苟兰英. ERCC1/BRCA1表达与基因多态性对是否使用顺铂化疗的晚期非小细胞肺癌患者的预后及预测价值[J]. 循证医学, 2013, 13(4): 207-210. DOI: 10.3969/j.issn.1671-5144.2013.04.007
    引用本文: 刘晓晴, 苟兰英. ERCC1/BRCA1表达与基因多态性对是否使用顺铂化疗的晚期非小细胞肺癌患者的预后及预测价值[J]. 循证医学, 2013, 13(4): 207-210. DOI: 10.3969/j.issn.1671-5144.2013.04.007
    shu
    LIU Xiao-qing, GOU Lan-ying. ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin[J]. Journal of Evidence-Based Medicine, 2013, 13(4): 207-210. DOI: 10.3969/j.issn.1671-5144.2013.04.007
    Citation: LIU Xiao-qing, GOU Lan-ying. ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin[J]. Journal of Evidence-Based Medicine, 2013, 13(4): 207-210. DOI: 10.3969/j.issn.1671-5144.2013.04.007
    shu

    ERCC1/BRCA1表达与基因多态性对是否使用顺铂化疗的晚期非小细胞肺癌患者的预后及预测价值

    ERCC1/BRCA1 Expression and Gene Polymorphisms as Prognostic and Predictive Factors in Advanced NSCLC Treated with or without Cisplatin

      摘要
    • 摘要: 21世纪肿瘤治疗的临床医学特征之一就是个体化治疗,作为肺癌治疗手段中的传统化疗,希望突破疗效瓶颈,避免过度和有害治疗,只有通过个体化治疗才是实现上述目标的唯一途径。在分子靶向个体化治疗浪潮的推动下,我们看到化疗相关的研究也正在如火如荼地进行着。

       

      • HTML全文
      • 参考文献(9)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回